Research3 years ago
Provider perspectives on the acceptability & tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: A qualitative study
The World Health Organization recommends dolutegravir (DTG) as the for first-line and second-line antiretroviral therapy (ART) worldwide. However, little is known about the acceptability and tolerability...
